Vote Scores

Home / Companies / Chong Kun Dang Pharmaceutical Corp. / 26 Mar 2025

Meeting · year to 30 June 202529 filers reporting

Chong Kun Dang Pharmaceutical Corp.: meeting of 26 Mar 2025

Votes reported on Form N-PX, item by item

29 Form N-PX filers reported votes at the Chong Kun Dang Pharmaceutical Corp. meeting of 26 Mar 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 89.5% of reported votes for; 9 filers withheld from or voted against at least one nominee.

114 vote records from 29 filers. 1 of the 29 filers that marked the item either way voted against management.

96.6% for3.4% against3.4% against management29 filers
2

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

34 vote records from 26 filers. 2 of the 26 filers that marked the item either way voted against management.

88.5% for11.5% against7.7% against management26 filers97.9% for2.1% against1.5% against management493,939 reported shares, counted once per item in this group
3

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

76 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers100.0% for0.0% against0.0% against management1,175,066 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors
VanguardFor
BlackRock and iSharesFor
FidelityFor
DimensionalFor
State Street and SPDRFor
American CenturyFor
Charles SchwabFor
Nuveen and TIAAFor
Goldman SachsFor
WisdomTreeFor
Northern Trust and FlexSharesFor
First TrustFor
Russell InvestmentsFor
Brighthouse FundsFor
AllianceBernsteinAgainst *
Hartford FundsFor

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Chong Kun Dang Pharmaceutical Corp. meeting?

29 Form N-PX filers reported votes at the meeting of 26 Mar 2025. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Chong Kun Dang Pharmaceutical Corp. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Chong Kun Dang Pharmaceutical Corp.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Chong Kun Dang Pharmaceutical Corp. with a meeting date within three days of 26 Mar 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.